Journal article
Novel treatments for hepatocellular cancer.
- Abstract:
-
Hepatocellular cancer (HCC) has always been considered a therapeutic challenge, given the cytoxic drug resistant nature of the cancer and associated disorder in liver function, reducing the safety of many conventional chemotherapy agents. The Multikinase inhibitor sorafenib has been found to prolong survival in patients with advanced HCC, by around 3months compared to placebo, but novel treatments need to be explored. Current experimental therapeutic approaches encompass a broad range of scie...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Cancer letters
- Volume:
- 286
- Issue:
- 1
- Pages:
- 114-120
- Publication date:
- 2009-12-01
- DOI:
- EISSN:
-
1872-7980
- ISSN:
-
0304-3835
- Source identifiers:
-
246554
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:246554
- UUID:
-
uuid:8c1bdc42-a306-4149-8e56-65a57b9e56e3
- Local pid:
- pubs:246554
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2009
If you are the owner of this record, you can report an update to it here: Report update to this record